Daniel Kraemmer

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A

Cihan Ay, Katarina D. Kovacevic, Daniel Kraemmer et al. · Blood · 2022 · 22 citations · Full text

Immunology, Pharmacotherapy, Aptamer Rondaptivon Pegol +16

Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillation

Stephan Nopp, Oliver Königsbrügge, Daniel Kraemmer et al. · European Journal of Internal Medicine · 2021 · 19 citations

All-cause Mortality, Thrombosis, Cardiomyopathy +6

Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition

Mario Kuttke, Emine Sahin, Julia Pisoni et al. · OncoImmunology · 2016 · 13 citations · Full text

The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders

Dino Mehic, Daniel Kraemmer, Alexander Tolios et al. · Journal of Thrombosis and Haemostasis · 2023 · 12 citations · Full text